Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Deals & Financings

Hansoh Enters $170 Million Agreement for Endometriosis/Uterine Fibroid Therapy
Epigenic Therapeutics Raises $20 Million in Angel and Pre-A Rounds for Epigenetic Drugs
Innovent to Partner two Sanofi Cancer Assets in China; Sanofi Invests $305 Million in Innovent
Genuine Biotech Files for Hong Kong IPO to Support Novel Drug Portfolio
Radiopharm Forms Collaboration to Develop PD-L1 Diagnostic/Therapeutic Antibody
ChinaBio Event
Beijing and Digital
November 8-11, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022